GlobalData provides unique and market-leading data and insights into the immunology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H2, 2021" provides an overview of Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH]...

Peanut Allergy – Global Clinical Trials Review, H2, 2021

  • $2,500
  • July 2021
GlobalData's clinical trial report, “Peanut Allergy - Global Clinical Trials Review, H2, 2021" provides an overview of Peanut Allergy Clinical trials scenario. This report provides top line data relating to...

Myasthenia Gravis – Global Clinical Trials Review, H2, 2021

  • $2,500
  • July 2021
GlobalData's clinical trial report, “Myasthenia Gravis - Global Clinical Trials Review, H2, 2021" provides an overview of Myasthenia Gravis Clinical trials scenario. This report provides top line data relating to...

Systemic Sclerosis (Scleroderma) – Epidemiology Forecast to 2030

  • $3,995
  • May 2021
Systemic sclerosis (SSc) is an autoimmune disorder of small arteries, microvessels, and connective tissue. SSc is characterized by the buildup of scar tissue (fibrosis) and vascular obliteration in the skin...

Systemic Sclerosis – Global Drug Forecast and Market Analysis to 2030

  • $10,995
  • May 2021
Systemic sclerosis (SSc) is a rare, multisystem autoimmune disease that causes progressive fibrosis of the skin and internal organs, as well as vascular dysfunction. The presentation of the disease is...

Plaque Psoriasis (Psoriasis Vulgaris) – Global Clinical Trials Review, H1, 2021

  • $2,500
  • April 2021
GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, H1, 2021" provides an overview of Plaque Psoriasis (Psoriasis Vulgaris) Clinical trials scenario. This report provides top...

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) – Global Clinical Trials Review, H1, 2021

  • $2,500
  • April 2021
GlobalData's clinical trial report, “Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H1, 2021" provides an overview of Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH]...

Myasthenia Gravis Disease – Global Clinical Trials Review, H1, 2021

  • $2,500
  • February 2021
GlobalData's clinical trial report, “Myasthenia Gravis Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Myasthenia Gravis Clinical trials scenario. This report provides top line data relating...

Peanut Allergy Disease – Global Clinical Trials Review, H1, 2021

  • $2,500
  • February 2021
GlobalData's clinical trial report, “Peanut Allergy Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Peanut Allergy Clinical trials scenario. This report provides top line data relating...

Sjogren’s Syndrome (SS) – Opportunity Analysis and Forecasts to 2029

  • $10,995
  • February 2021
Sjögren’s syndrome (SS) is a chronic and systemic autoimmune inflammatory disorder in which an initial immunological attack that primarily targets the lacrimal and salivary glands. Although most characteristically clinical features...